Menarini Group, The - SWOT Analysis company profile is the essential source for top-level company data and information. Menarini Group, The - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
The Menarini Group (Menarini) is the largest pharmaceutical company in Italy. This privately held group is engaged in the development and manufacture of pharmaceutical products mainly for cardiovascular diseases, oncology, and pain, inflammation and asthma. Menarini has established a presence throughout Europe, Latin America, Asia, and Africa. The group is headquartered in Florence, Italy and employed 12,890 people at the end of the year 2010. The group recorded revenues of E3,031 million (4,021.2 million*) during the financial year (FY) ended December 2010, an increase of 8.4% over FY2009. Menarini has not provided other financial data including operating and net profits. * Calculated using the constant currency conversion rate of E1 = $1.3267 for the financial year ended December 31, 2010.
Scope of the Report
Provides all the crucial information on Menarini Group, The required for business and competitor intelligence needs
Contains a study of the major internal and external factors affecting Menarini Group, The in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Menarini Group, The
Data is supplemented with details on Menarini Group, The history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Menarini Group, The
Reasons to Purchase
Support sales activities by understanding your customers’ businesses better
Understand prospective partners and suppliers
Keep fully up to date on your competitors’ business structure, strategy and prospects
Obtain the most up to date company information available